6505--japanese encephalitis virus vaccine ixiaro

Award Notice Posted

Solicitation number
36C25227N0099
Agency
Awarded
Set-aside
No set-aside

Opportunity facts

Contract number
36F79725D024936C25227N0099

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs Veterans Integrated Service Network 12 awarded a $787,392 contract to Valneva USA, Inc. for Japanese Encephalitis Virus Vaccine IXIARO on October 1, 2026.

The award was made as a sole-source delivery order under the existing FSS Contract 36F79725D0249 (Pharmaceutical VA NAC schedule) pursuant to GSAR 538.7104-4, justified on the basis that IXIARO is the only JE vaccine licensed and available for use in the United States. The vaccine is required for Navy recruits prior to deployment and is indicated for active immunization against Japanese encephalitis virus in individuals 2 months of age and older. The specific product is IXIARO 6MCG (NDC: 42515-0002-01), manufactured by Valneva Scotland Ltd. Valneva USA, Inc. is located in Bethesda, Maryland. The VA Network Contracting Office in Milwaukee, Wisconsin issued the contract under solicitation 36C25227N0099. The contracting officer is Stacy Massey. No set-aside restrictions applied.

Notice text

Awarded contract 36F79725D024936C25227N0099 to VALNEVA USA, INC. for 787392.00 on 2026-10-01.

Files

File Type Posted
GSAR 538 Limiting_Sources_Justification_OVER_SAT.pdf PDF
36F79725D0249 36C25227N0099_1.docx DOCX document

Notice history

Notice Type Posted
This notice Latest Award Notice
6505--japanese encephalitis virus vaccine ixiaro Award Notice
6505--japanese encephalitis virus vaccine ixiaro Original Award Notice

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors